"10.1371_journal.pone.0075157","plos one","2013-09-20T00:00:00Z","Irit Ben Aharon; Hadas Bar Joseph; Moran Tzabari; Boris Shenkman; Nahid Farzam; Mattan Levi; Ruth Shalgi; Salomon M Stemmer; Naphtali Savion","Institute of Oncology, Davidoff Center and Rabin Medical Center, Petah-Tiqva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Amalia Biron Research Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel Hashomer, Israel; Goldschleger Eye Research Institute and Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel","Conception and design: IBA RS SMS NS. Development of methodology: MT IBA ML RS NS. Writing, review and/or revision of the manuscript: IBA RS SMS NS. Administrative, technical, or material support: MT IBA ML NF BS HBJ. Study supervision: RS SMS NS. Acquisition of data: MT IBA ML NF BS HBJ. Analysis and interpretation of data: IBA RS SMS NS. Analysis tools: NF BS HBJ ML NS.","N. Savion is an inventor of the CPA technology and a founder of the Company developing the Impact-R (Matis Medical (Brussels, Belgium). Co-author Salomon M. Stemmer is a PLOS ONE Editorial Board member. One of the authors is employed by commercial company (Dr N. Savion as stated is employed by the Company developing the Impact-R, Matis Medical (Brussels, Belgium)). There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","09","Irit Ben Aharon","IBA",9,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE
